hims retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam hims and hers semaglutide This

Glucagon The odd one out, and the reason Retatrutide exists at all

Food companies, including Conagra Brands and Nestle, are already dealing with shifts in consumer tastes toward higher protein and smaller portions due to the popularity of weight-loss injections, and analysts believe widespread GLP-1 adoption could mean long-term changes in demand

Long-term data beyond 12 weeks in humans does not exist from controlled trials

"And so what we've learned over the years is that hitting the system in more than one place can often bring additive weight loss." While losing a large amount of weight may be the goal for some people, for others, it is not, which is why it's important that multiple drugs are available, according to Aronne